Dopamine Transporter Forms Stable Dimers in the Live Cell Plasma Membrane in a Phosphatidylinositol 4,5-bisphosphate-independent Manner

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2019 Feb 2

PMID 30705091

Citations 18

Authors

Anand Kant Das

Oliver Kudlacek

Florian Baumgart

Kathrin Jaentsch

Thomas Stockner

Harald H Sitte

Gerhard J Schutz

Affiliations

Soon will be listed here.

Abstract

The human dopamine transporter (hDAT) regulates the level of the neurotransmitter dopamine (DA) in the synaptic cleft and recycles DA for storage in the presynaptic vesicular pool. Many neurotransmitter transporters exist as oligomers, but the physiological role of oligomerization remains unclear; for example, it has been speculated to be a prerequisite for amphetamine-induced release and protein trafficking. Previous studies point to an oligomeric quaternary structure of hDAT; however, the exact stoichiometry and the fraction of co-existing oligomeric states are not known. Here, we used single-molecule brightness analysis to quantify the degree of oligomerization of heterologously expressed hDAT fused to monomeric GFP (mGFP-hDAT) in Chinese hamster ovary (CHO) cells. We observed that monomers and dimers of mGFP-hDAT co-exist and that higher-order molecular complexes of mGFP-hDAT are absent at the plasma membrane. The mGFP-hDAT dimers were stable over several minutes, and the fraction of dimers was independent of the mGFP-hDAT surface density. Furthermore, neither oxidation nor depletion of cholesterol had any effect on the fraction of dimers. Unlike for the human serotonin transporter (hSERT), in which direct binding of phosphatidylinositol 4,5-bisphosphate (PIP) stabilized the oligomers, the stability of mGFP-hDAT dimers was PIP independent.

Citing Articles

Oligomerization of Monoamine Transporters.

Paul A, Shukla D Subcell Biochem. 2024; 104:119-137.

PMID: 38963486 DOI: 10.1007/978-3-031-58843-3_7.

Ion and lipid orchestration of secondary active transport.

Drew D, Boudker O Nature. 2024; 626(8001):963-974.

PMID: 38418916 DOI: 10.1038/s41586-024-07062-3.

A comparative review on the well-studied GAT1 and the understudied BGT-1 in the brain.

Bhatt M, Gauthier-Manuel L, Lazzarin E, Zerlotti R, Ziegler C, Bazzone A Front Physiol. 2023; 14:1145973.

PMID: 37123280 PMC: 10137170. DOI: 10.3389/fphys.2023.1145973.

Monte Carlo simulations for the evaluation of oligomerization data in TOCCSL experiments.

Bodner C, Kiesenhofer D, Schutz G, Brameshuber M Biophys J. 2023; 122(11):2367-2380.

PMID: 37088991 PMC: 10257147. DOI: 10.1016/j.bpj.2023.04.021.

Overview of the structure and function of the dopamine transporter and its protein interactions.

Nepal B, Das S, Reith M, Kortagere S Front Physiol. 2023; 14:1150355.

PMID: 36935752 PMC: 10020207. DOI: 10.3389/fphys.2023.1150355.

References

Hamilton P, Belovich A, Khelashvili G, Saunders C, Erreger K, Javitch J . PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein. Nat Chem Biol. 2014; 10(7):582-589. PMC: 4062427. DOI: 10.1038/nchembio.1545. View

Christian A, Haynes M, Phillips M, Rothblat G . Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res. 1997; 38(11):2264-72. View

Rothman R, Baumann M . Monoamine transporters and psychostimulant drugs. Eur J Pharmacol. 2003; 479(1-3):23-40. DOI: 10.1016/j.ejphar.2003.08.054. View

Kadamur G, Ross E . Mammalian phospholipase C. Annu Rev Physiol. 2012; 75:127-54. DOI: 10.1146/annurev-physiol-030212-183750. View

Sampson N, Vrielink A . Cholesterol oxidases: a study of nature's approach to protein design. Acc Chem Res. 2003; 36(9):713-22. DOI: 10.1021/ar9800587. View

Sitte H, Farhan H, Javitch J . Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol Interv. 2004; 4(1):38-47. DOI: 10.1124/mi.4.1.38. View

Magnani F, Tate C, Wynne S, Williams C, Haase J . Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J Biol Chem. 2004; 279(37):38770-8. DOI: 10.1074/jbc.M400831200. View

Rahbek-Clemmensen T, Lycas M, Erlendsson S, Eriksen J, Apuschkin M, Vilhardt F . Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains. Nat Commun. 2017; 8(1):740. PMC: 5622129. DOI: 10.1038/s41467-017-00790-3. View

Seidel S, Singer E, Just H, Farhan H, Scholze P, Kudlacek O . Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol. 2004; 67(1):140-51. DOI: 10.1124/mol.67.1.. View

10.

Hastrup H, Karlin A, Javitch J . Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc Natl Acad Sci U S A. 2001; 98(18):10055-60. PMC: 56914. DOI: 10.1073/pnas.181344298. View

11.

Kilic F, Rudnick G . Oligomerization of serotonin transporter and its functional consequences. Proc Natl Acad Sci U S A. 2000; 97(7):3106-11. PMC: 16200. DOI: 10.1073/pnas.97.7.3106. View

12.

Vaughan R, Foster J . Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol Sci. 2013; 34(9):489-96. PMC: 3831354. DOI: 10.1016/j.tips.2013.07.005. View

13.

Baucum 2nd A, Rau K, Riddle E, Hanson G, Fleckenstein A . Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. J Neurosci. 2004; 24(13):3436-43. PMC: 6730025. DOI: 10.1523/JNEUROSCI.0387-04.2004. View

14.

Sucic S, El-Kasaby A, Kudlacek O, Sarker S, Sitte H, Marin P . The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C. J Biol Chem. 2011; 286(18):16482-90. PMC: 3091253. DOI: 10.1074/jbc.M111.230037. View

15.

Javanainen M, Martinez-Seara H, Vattulainen I . Excessive aggregation of membrane proteins in the Martini model. PLoS One. 2017; 12(11):e0187936. PMC: 5683612. DOI: 10.1371/journal.pone.0187936. View

16.

Egana L, Cuevas R, Baust T, Parra L, Leak R, Hochendoner S . Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3. J Neurosci. 2009; 29(14):4592-604. PMC: 2846176. DOI: 10.1523/JNEUROSCI.4559-08.2009. View

17.

Pizzo A, Karam C, Zhang Y, Yano H, Freyberg R, Karam D . The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila. Mol Psychiatry. 2012; 18(7):824-33. PMC: 3582826. DOI: 10.1038/mp.2012.82. View

18.

de Meyer F, Venturoli M, Smit B . Molecular simulations of lipid-mediated protein-protein interactions. Biophys J. 2008; 95(4):1851-65. PMC: 2483748. DOI: 10.1529/biophysj.107.124164. View

19.

Jess U, Betz H, Schloss P . The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein. FEBS Lett. 1996; 394(1):44-6. DOI: 10.1016/0014-5793(96)00916-7. View

20.

Torres G, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao W . Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem. 2002; 278(4):2731-9. DOI: 10.1074/jbc.M201926200. View